（编辑 任世碧） 证券日报网讯 11月26日晚间，九强生物发布公告称，公司因实施2025年第二次中期权益分派，根据 《北京九强生物技术股份有限公司创业板向不特定对象发行可转换公司债券募集说明书》及相关规定， 公司可转换公司债券（债券代码：123150；债券简称：九强转债）自2025年11月19日至本次权益分派股 权登记日（2025年11月26日）止暂停转股。根据规定，"九强转债"将于本次权益分派股权登记日后的第 一个交易日即2025年11月27日起恢复转股。 ...

Core Viewpoint - Jiukang Bio announced a reduction in the conversion price of its convertible bonds from 16.68 yuan per share to 16.48 yuan per share, effective from November 27, 2025 [1] Group 1 - The adjustment in the conversion price reflects a strategic decision by the company to enhance the attractiveness of its convertible bonds [1] - The new conversion price will take effect on the ex-dividend date, indicating a planned timeline for the adjustment [1]

（编辑 楚丽君） 证券日报网讯 11月17日晚间，九强生物发布公告称，自2025年11月19日起至2025年第二次中期权益分 派股权登记日止，公司可转换公司债券（债券代码：123150；债券简称：九强转债）将暂停转股，2025 年第二次中期权益分派股权登记日后的第一个交易日起恢复转股。在上述暂停转股期间，公司可转换公 司债券正常交易，敬请"九强转债"债券持有人留意。 ...

Core Viewpoint - The article discusses recent developments in various companies and convertible bonds, highlighting share reduction plans, technology contracts, and new stock listings. Group 1: Share Reduction and Convertible Bonds - The actual controller of Fuchun Dyeing and Weaving and its concerted actors plan to reduce their holdings by no more than 1% of the company's shares [1] - Lu Shan Convertible Bond is subject to strong redemption [1][2] - Song Sheng Convertible Bond will not undergo strong redemption [1][2] - Jiu Qiang Convertible Bond and Yang Feng Convertible Bond will not be adjusted [1][2] Group 2: Technology Contracts and New Listings - Fengshan Group signed a technology development contract with Tsinghua University for sodium-ion battery electrolyte and solid-state lithium-ion battery electrolyte projects [1] - New stocks from Yunhan Chip City and Ruili Kemi are available for subscription on the Shanghai and Shenzhen stock exchanges [1]

Core Viewpoint - The company has decided not to lower the conversion price of its convertible bonds, "Jiuqiang Convertible Bonds," and will not propose any downward adjustments for the next six months [1] Summary by Relevant Sections - **Board Meeting Decision** - The fifth board meeting of the company on September 18, 2025, approved the proposal not to adjust the conversion price of "Jiuqiang Convertible Bonds" downwards [1] - **Future Conditions** - For the next six months, from September 19, 2025, to March 18, 2026, the company will not propose any downward adjustment even if the conditions for such an adjustment are triggered [1] - The next period for potential adjustment will start from March 19, 2026, which is the first trading day after the non-adjustment period ends [1] - **Future Board Meetings** - If the conditions for downward adjustment are triggered again, the board will convene to decide whether to exercise the right to adjust the conversion price [1]

Group 1 - Company Jiukang Bio announced the convening of its 18th meeting of the 5th Board of Directors on September 18, 2025, using a combination of on-site and remote voting methods [1] - The meeting reviewed the proposal regarding not to lower the conversion price of "Jiukang Convertible Bonds" [1]

Group 1 - The company, Jiukang Biotechnology, announced that the period for triggering the conversion price adjustment condition starts from August 27, 2025, and ends on September 11, 2025 [1] - During this period, the company's stock has had ten trading days where the closing price was below 85% of the current conversion price, which is 14.43 yuan per share from August 27 to September 4, 2025, and 14.18 yuan per share from September 5, 2025 [1] - If the conversion price adjustment condition is triggered, the company will follow the relevant regulations of the Shenzhen Stock Exchange and the provisions of the prospectus for the issuance of convertible bonds to perform subsequent review procedures and information disclosure obligations [1]

Core Viewpoint - Beijing Jiukang Biotechnology Co., Ltd. announces the suspension of the conversion of its convertible bonds "Jiukang Convertible Bonds" (bond code: 123150) during the rights distribution period from August 28, 2025, to September 4, 2025, and will resume conversion on September 5, 2025 [1] Summary by Relevant Sections - The company guarantees the authenticity, accuracy, and completeness of the information disclosed, ensuring no false records, misleading statements, or significant omissions [1] - The suspension of the bond conversion is in accordance with the regulations outlined in the prospectus for the issuance of convertible bonds to unspecified objects [1] - Bondholders are advised to pay attention to the resumption of conversion on the first trading day after the rights distribution registration date [1]

Core Viewpoint - The report outlines the management of the convertible bond "Jiukang Convertible Bond" issued by Beijing Jiukang Biotechnology Co., Ltd., detailing its issuance, terms, and adjustments to the conversion price due to dividend distributions and share repurchases [3][4][20]. Group 1: Bond Issuance Details - The total issuance amount of the convertible bond is RMB 1.139 billion, with 11,390,000 bonds issued at a face value of RMB 100 each [4][12]. - The bond has a maturity period of 6 years, from June 30, 2022, to June 29, 2028 [5][9]. - The bond's interest rates are structured to increase over the years, starting from 0.3% in the first year to 3.0% in the sixth year [5][9]. Group 2: Conversion Price Adjustments - The initial conversion price was set at RMB 17.63 per share, which was adjusted to RMB 17.53 following a cash dividend distribution [11][12]. - Subsequent adjustments were made to the conversion price due to further cash dividends, resulting in a new conversion price of RMB 17.35 and then RMB 16.95 [15][19]. - The latest adjustment brought the conversion price down to RMB 16.68, effective from September 5, 2025, due to the latest dividend distribution [20]. Group 3: Credit Rating and Management - The bond has been rated AA- by China Chengxin International Credit Rating Co., Ltd., with a stable outlook [9]. - The management of the bond is overseen by China International Capital Corporation, which is responsible for ensuring the interests of bondholders are protected [20].

Core Viewpoint - The company has announced an adjustment to the conversion price of its convertible bonds due to changes in its share capital structure following a cash dividend distribution [1][2][4]. Summary by Sections Conversion Price Adjustment Basis - The adjustment of the conversion price is based on the company's regulations regarding changes in share capital, including stock dividends, capital increases, and cash dividends [1][2]. Reason for Adjustment - The conversion price was adjusted because the company repurchased 3,544,084 shares that did not participate in the cash dividend distribution. The total cash dividend distributed was 174,829,363.20 yuan, calculated based on the number of shares participating in the distribution and the dividend per share of 0.30 yuan [2][3]. Result of Adjustment - The conversion price of the "Jiukang Convertible Bonds" will be adjusted from 16.98 yuan per share to 16.68 yuan per share, effective from September 5, 2025. This adjustment reflects the reduction in the cash dividend per share due to the repurchased shares [4].